The DOI matches its Crossref record; 59 of the 63 references it cites were found in a registry or an index.
Pharmacotherapy for Borderline Personality Disorder: A Review of the Literature and Recommendations for Treatment
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Personality disorders are relatively common in the community, and effective treatment is available for some.
“As PDs are relatively common in the community, and effective treatment is available for some, health care workers should be aware of the strong link between PDs and work force exclusion.”
From Personality disorders are important risk factors for disability pensioning (2014) · cites this paper as [14]
Effective therapies have become available for the treatment of several personality disorders.
“During the past two decades, effective therapies have become available for the treatment of several PDs [14–16].”
From Personality disorders are important risk factors for disability pensioning (2014) · cites this paper as [14]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,842
(1993) · Cited by 7,136
Self-citation(1993) · Medical Entomology and Zoology · Cited by 2,491
Self-citationElkin, I. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110013002 · Cited by 2,300
Serotonergic Studies in Patients With Affective and Personality Disorders
Coccaro, E. F. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810070013002 · Cited by 1,085
The diagnostic interview for borderline patients
Gunderson, J. G., Kolb, J. E., & Austin, V. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.7.896 · Cited by 521
Pharmacotherapy of Borderline Personality Disorder
Cowdry, R. W. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800260015002 · Cited by 473
The Validity of DSM-III Borderline Personality Disorder
Pope, H. G. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790010025003 · Cited by 458
The Chestnut Lodge Follow-up Study
McGlashan, T. H. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790170047006 · Cited by 447
Self-injurious behavior: a review of the behavior and biology of self- mutilation
Winchel, R., & Stanley, M. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.3.306 · Cited by 431
The Chestnut Lodge Follow-up Study: III. Long-term Outcome of Borderline Personalities
McGlashan, T. H. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800010022003 · Cited by 304
Epidemiology of Borderline Personality Disorder
Widiger, T. A., & Weissman, M. M. (1991) · Psychiatric Services · doi:10.1176/ps.42.10.1015 · Cited by 287
Effect of Fluoxetine on Anger in Symptomatic Volunteers With Borderline Personality Disorder
Salzman, C., Wolfson, A. N., Schatzberg, A. F., Looper, J., Henke, R., Albanese, M. A., Schwartz, J., & Miyawaki, E. K. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199502000-00005 · Cited by 279
Progress in Pharmacotherapy of Borderline Disorders
Soloff, P. H. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800070081010 · Cited by 249
Borderline and Schizotypal Personality Disorders Treated With Low-Dose Thiothixene vs Placebo
Goldberg, S. C. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800070070009 · Cited by 248
Agranulocytosis: incidence and risk factors.
Kavoussi, R. J., LIU, J. I., & Coccaro, E. F. (1994) · PubMed · Cited by 238
Efficacy of Phenelzine and Haloperidol in Borderline Personality Disorder
Soloff, P. H. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820170055007 · Cited by 234
Pilkonis, P. A., & Frank, E. F. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.4.435 · Cited by 215
Alprazolam-induced dyscontrol in borderline personality disorder
Gardner, D. L., & Cowdry, R. W. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.1.98 · Cited by 210
Long-term follow-up of borderline patients in a general hospital
Paris, J., Brown, R., & Nowlis, D. (1987) · Comprehensive Psychiatry · doi:10.1016/0010-440x(87)90019-8 · Cited by 209
Comorbidity of Borderline Personality Disorder
Fyer, M. R. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800280060008 · Cited by 190
Paradoxical reactions to benzodiazepines.
Hall, R., & Zisook, S. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01844.x · Cited by 173
The interface between borderline personality disorder and affective disorder
Gunderson, J. G., & Elliott, G. R. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.3.277 · Cited by 170
Lithium Therapy for Borderline Patients: Preliminary Findings
Links, P. S., Steiner, M. S., Boiago, I., & Irwin, D. J. (1990) · Journal of Personality Disorders · doi:10.1521/pedi.1990.4.2.173 · Cited by 170
Skodol, A. E., Buckley, P. F., & Charles, E. (1983) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198307000-00003 · Cited by 158
Substitution Pharmacotherapies for Opioid Addiction: From Methadone to LAAM and Buprenorphine
Ling, W. W., Rawson, R. A., & Compton, M. A. (1994) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1994.10472259 · Cited by 135
Diagnosing Personality Disorder in Depressed Patients
Zimmerman, M. A. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800320045005 · Cited by 134
Borderline Personality Disorder
Kroll, J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780340073009 · Cited by 129
Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine
Cornelius, J. R., Soloff, P. H., Perel, J. M., & Ulrich, R. F. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1843 · Cited by 113
Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol
Serban, G., & Siegel, S. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1455 · Cited by 113
Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior.
Salzman, C., Solomon, D., Miyawaki, E. K., Glassman, R. B., Rood, L., Flowers, E., & Thayer, S. (1991) · PubMed · Cited by 106
A medication algorithm for treatment of bipolar rapid cycling?
Calabrese, J. R., & Woyshville, M. J. (1995) · PubMed · Cited by 101
Suicide attempts in patients with borderline personality disorder
Fyer, M. R., FRANCES, A. J., Sullivan, T., Hurt, S. W., & Clarkin, J. F. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.6.737 · Cited by 100
An open trial of valproate in borderline personality disorder.
Stein, D. J., Simeon, D., Frenkel, M., Islam, M. N., & Hollander, E. (1995) · PubMed · Cited by 90
Borderline Patients: Psychoanalytic Perspectives
Gunderson, J. G. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.4.509-a · Cited by 89
Psychotherapy and Psychological Trauma in Borderline Personality Disorder
Perry, J. C., Herman, J. L., van der Kolk, B. A., & Hoke, L. A. (1990) · Psychiatric Annals · doi:10.3928/0048-5713-19900101-08 · Cited by 79
A profile of the noncompliant patient: A thirty-month review of outpatient psychiatry referrals
Matas, M., Staley, D., & Griffin, W. (1992) · General Hospital Psychiatry · doi:10.1016/0163-8343(92)90037-b · Cited by 78
Stability and distinctness of borderline personality disorder
Barasch, A., Frances, A., Hurt, S. W., Clarkin, J. F., & Cohen, S. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.12.1484 · Cited by 77
Response of borderline patients to loxapine and chlorpromazine.
Leone, N. (1982) · PubMed · Cited by 76
Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression.
Parsons, B., Quitkin, F. M., McGrath, P. J., Stewart, J. W., TRICAMO, E., Ocepek‐Welikson, K., Harrison, W. M., Rabkin, J. G., Wager, S. G., & Nunes, E. (1989) · PubMed · Cited by 74
Are There Borderlines in Britain?
Kroll, J. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290010038007 · Cited by 69
Can We Study (Treat) Borderline Patients? Attrition From Research and Open Treatment
Kelly, T. M., Soloff, P. H., Cornelius, J. R., George, A., Lis, J. A., & Ulrich, R. F. (1992) · Journal of Personality Disorders · doi:10.1521/pedi.1992.6.4.417 · Cited by 56
Behavioral effects of carbamazepine.
Dalby, M. A. (1975) · PubMed · Cited by 52
Development of Melancholia During Carbamazepine Treatment in Borderline Personality Disorder
Gardner, D. L., & Cowdry, R. W. (1986) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198608000-00008 · Cited by 43
Is there any drug treatment of choice for the borderline patient?
Soloff, P. H. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb05818.x · Cited by 33
The depressed borderline: one disorder or two?
Soloff, P. H., Cornelius, J., & George, A. (1991) · PubMed · Cited by 33
Teicher, M. H., Glod, C. A., Aaronson, S. T., Gunter, P. A., Schatzberg, A. F., & Cole, J. O. (1989) · PubMed · Cited by 29
Biological and Pharmacological Aspects of Borderline Personality Disorder
Coccaro, E. F., & Kavoussi, R. J. (1991) · Psychiatric Services · doi:10.1176/ps.42.10.1029 · Cited by 28
Symptom-Oriented Psychopharmacology for Personality Disorders
Soloff, P. H. (1998) · Journal of Psychiatric Practice · doi:10.1097/00131746-199801000-00001 · Cited by 27
Haloperidol vs. phenelzine in continuation therapy of borderline disorder.
Cornelius, J. R., Soloff, P. H., George, A., Ulrich, R. F., & Perel, J. M. (1993) · PubMed · Cited by 25
Waldinger, R. J., & Frank, A. F. (1989) · Psychiatric Services · doi:10.1176/ps.40.7.712 · Cited by 22
Patient dissatisfaction and attempted suicide
Richman, J., & Charles, E. (1976) · Community Mental Health Journal · doi:10.1007/bf01419758 · Cited by 17
Modestin, J., Abrecht, I., Tschaggelar, W., & Hoffmann, H. (1983) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00346086 · Cited by 15
Personality disorders among psychiatric inpatients
Kullgren, G. (1992) · Nordic Journal of Psychiatry · doi:10.3109/08039489209106179 · Cited by 13
Pharmacotherapy of Borderline States
Brinkley, J. R. (1993) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30155-2 · Cited by 12
Prognosis of the Borderline Disorders
Dahl, A. A. (2010) · Psychopathology · doi:10.1159/000284431 · Cited by 11
DSM-III Diagnosed Borderline Personality Disorder and Depression
Manos, N., Vasilopoulou, E., & Sotiriou, M. (1987) · Journal of Personality Disorders · doi:10.1521/pedi.1987.1.3.263 · Cited by 9
Dr. Winchel and Dr. Stanley Reply
Winchel, R., & STANLEY, M. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1618 · Cited by 5
Comparative Treatments for Borderline Personality Disorder
Tutek, D. A., & Linehan, M. M. (1993) · Springer eBooks · doi:10.1007/978-1-4615-2914-9_15 · Cited by 3
Self-citation
Flagged first, then by citations
4 of the 63 references couldn’t be matched to a known paper.
Research works printed but not linked: 6
- Kavoussi, R. J., Liu, J., & Coccaro, E. F. (1994). An open trial of sertraline in personality disordered patients with impulsive aggression. Journal of Clinical Psychiatry, 55, 137–141.
- Linehan, M. M., & Dimeff, L. A. (1995, November). Dialectical behavior therapy for women with Borderline Personality Disorder and substance abuse. Paper presented as part of symposium, “Innovative Cognitive and Behavioral Treatments of Drug and Alcohol Abuse,” at the Association for the Advancement of Behavior Therapy, Washington, DC.
- Markowitz, P. (1995). Pharmacotherapy of impulsivity, aggression, and related disorders. In E. Hollander & D. J. Stein (Eds.), Impulsivity and aggression. New York: Wiley.
- National Institute of Health. (1997). Effective medical treatment of heroin addiction. National Institute of Health Concensus Statement, 15(6), 17–19.
- Soloff, P. H., Cornelius, J., & George, A. (1991). Relationship between Axis I and Axis II disorders: Implications for treatment. Psychopharmacology Bulletin, 27, 23–30.
- Widiger, T. A., & Frances, A. J. (1989). Epidemiology, diagnosis, and comorbidity of borderline personality disorder. In A. Tasman, R. E. Hales, & A. J. Frances (Eds.), American Psychiatric press review of psychiatry, (Vol. 8, pp. 8–24). Washington, DC: American Psychiatric Association.
Cited by
Sorted by citations
Dialectical behavior therapy as treatment for borderline personality disorder
May, J. M., Richardi, T. M., & Barth, K. S. (2016) · Mental Health Clinician · doi:10.9740/mhc.2016.03.62 · Cited by 104
Personality disorders are important risk factors for disability pensioning
Østby, K. A., Czajkowski, N., Knudsen, G. P., Ystrom, E., Gjerde, L. C., Kendler, K. S., Ørstavik, R. E., & Reichborn-Kjennerud, T. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0878-0 · Cited by 72
“During the past two decades, effective therapies have become available for the treatment of several PDs [14–16].”
Collaborative Deprescribing in Borderline Personality Disorder: A Narrative Review
Fineberg, S. K., Gupta, S., & Leavitt, J. (2019) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000200 · Cited by 37
Neacsiu, A. D., Eberle, J. W., Keng, S., Fang, C. M., & Rosenthal, M. Z. (2017) · Current Psychiatry Reviews · doi:10.2174/1573400513666170612122034 · Cited by 28
Borderline Personality Disorder: An Overview
Adams, H. E., Bernat, J., & Luscher, K. A. (2002) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47377-1_17 · Cited by 37
Borderline personality disorder: current drug treatments and future prospects
Olabi, B., & Hall, J. (2010) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622310368455 · Cited by 19
“Overview Although most qualitative, narrative reviews suggest that there is a promising role for medications in the treatment of BPD [Saunders and Silk, 2009; Abraham and Calabrese, 2008; Bellino et al. 2008; Dı́az-Marsá et al. 2008; Grootens and Verkes, 2005; Lieb et al. 2004; Markovitz, 2004; Raj, 2004; Zanarini, 20…”
BackgroundWrege, J. S., Busmann, M., Meyer, A. H., Euler, S., Lang, U. E., & Walter, M. (2020) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2526 · Cited by 8
El paciente que padece un trastorno de personalidad en el trabajo
Herrer, M. G., Adán, J. C. M., & Jiménez, B. M. (2010) · Medicina y Seguridad del Trabajo · doi:10.4321/s0465-546x2010000300005 · Cited by 7
Pharmacological Treatment of Non-suicidal Self-injury and Eating Disorders
Plener, P. L., & Schulze, U. (2013) · Springer eBooks · doi:10.1007/978-3-642-40107-7_12 · Cited by 4
Combined treatments for mental disorders: Clinical dilemmas.
Sammons, M. T. (2004) · American Psychological Association eBooks · doi:10.1037/10415-001 · Cited by 4
EL TRASTORNO LÍMITE DE LA PERSONALIDAD: CONTROVERSIAS ACTUALES
Caballo, V. E., & Camacho, S. (2000) · Americanae (AECID Library) · Cited by 3
Differential Diagnosis of Borderline Personality Disorder from Bipolar Disorder
Hatchett, G. T. (2010) · Journal of Mental Health Counseling · doi:10.17744/mehc.32.3.n682682184554445 · Cited by 5
“(American Psychiatric Association; Dimeff et al., 1999).”
BackgroundLieb, K. (2011) · Springer eBooks · doi:10.1007/978-3-642-25476-5_19
Metadata
- Authors
- Dimeff, L. A., McDavid, J., & Linehan, M. M.
- Affiliations
- University of Washington (US)
- Venue
- Journal of Clinical Psychology in Medical Settings
- Published
- 1999-03
- Volume
- 6
- Issue
- 1
- Pages
- 113-138
- ISSN
- 1068-9583 (ISSN-L)
- 1573-3572
- OpenAlex
- W170118819
- Cited by
- 13
- References
- 63
- Citations by year
- 2020: 1 · 2019: 1 · 2017: 1 · 2016: 1 · 2014: 1 · 2013: 1
- FWCI
- 0.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of Clinical Psychology in Medical Settings (publishedVersion)
- Funders
- National Institute of Mental Health
- National Institute on Drug Abuse
- Topics
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- borderline personality disorder, pharmacotherapy, psychotropic drugs, treatment guidelines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review